Published Date:2022-06-22 Original Link:https://www.onenessbio.com/en/news_detail170_2.htm No 1 Date of announcement 2022/06/22 Time of announcement 17:25:53 Subject Oneness announces the information about the investor’s conference of 2022 Q2. To which item it meets paragraph 12 Date of events 2022/06/29 Statement Date of institutional investor conference:2022/06/29 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference:Online Investor...Read More
Published Date:2022-06-02 Original Link:https://www.onenessbio.com/en/news_detail169_2.htm No 1 Date of announcement 2022/06/02 Time of announcement 20:24:50 Subject The findings of the MoA studies on Fespixon(ON101) under collaboration with TMU and NYCU have been accepted and published by a renown SCI journal, JID Innovations To which item it meets paragraph 53 Date of events 2022/06/02 Statement Date of...Read More
Published Date:2022-05-26 Original Link:https://www.onenessbio.com/en/news_detail168_2.htm No 1 Date of announcement 2022/05/26 Time of announcement 16:41:48 Subject Oneness Biotech Co.,LTD receives a China patent on antagonistic PDL1 aptamers. To which item it meets paragraph 53 Date of events 2022/05/26 Statement Date of occurrence of the event:2022/05/26 Company name:ONENESS BIOTECH CO., LTD. Relationship to the Company (please enter...Read More
Published Date:2022-05-24 Original Link:https://www.onenessbio.com/en/news_detail167_2.htm No 3 Date of announcement 2022/05/24 Time of announcement 19:17:23 Subject The Annual General Shareholders’ Meeting approved the removal of non-competition restriction on the newly-elected director. To which item it meets paragraph 21 Date of events 2022/05/24 Statement Date of the shareholders’ meeting resolution:2022/05/24 Name and title of the managerial officer...Read More
Published Date:2022-05-24 Original Link:https://www.onenessbio.com/en/news_detail166_2.htm No 2 Date of announcement 2022/05/24 Time of announcement 19:09:21 Subject By-election of one director of the board in 2022 shareholders’ meeting To which item it meets paragraph 6 Date of events 2022/05/24 Statement Date of occurrence of the change:2022/05/24 Elected or changed position (Please enter institutional director, institutional supervisor, independent...Read More
Published Date:2022-05-24 Original Link:https://www.onenessbio.com/en/news_detail165_2.htm No 1 Date of announcement 2022/05/24 Time of announcement 19:02:49 Subject Oneness announce the important resolutions of the 2022 Annual General Shareholders’ Meeting To which item it meets paragraph 18 Date of events 2022/05/24 Statement Date of the shareholders’ meeting:2022/05/24 Important resolutions I.Profit distribution/deficit compensation:Approved the 2021 deficit compensation proposal. Important...Read More
Published Date:2022-05-11 Original Link:https://www.onenessbio.com/en/news_detail164_2.htm No 1 Date of announcement 2022/05/11 Time of announcement 17:37:30 Subject The Company’s 2022Q1 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2022/05/11 Statement Date of the board of directors submitted or approved:2022/05/11 Date of the audit committee...Read More
Published Date:2022-05-02 Original Link:https://www.onenessbio.com/en/news_detail163_2.htm No 1 Date of announcement 2022/05/02 Time of announcement 20:10:48 Subject Oneness received the notification by the international CRO on the unblinded data of FB825 Phase 2a study in moderate-to-severe atopic dermatitis in the U.S. To which item it meets paragraph 10 Date of events 2022/05/02 Statement Product:FB825 Anti-CεmX monoclonal antibody...Read More
Published Date:2022-04-18 Original Link:https://www.onenessbio.com/en/news_detail160_3.htm No 1 Date of announcement 2022/04/18 Time of announcement 19:11:58 Subject The Food and Drug Administration–Philippines (PFDA) has accepted the NDA application of the diabetic foot ulcer new drug, Fespixon To which item it meets paragraph 10 Date of events 2022/04/18 Statement Product:ON101 Diabetic foot ulcer new drug Mass production date:NA...Read More
